My clinical areas of interest are the appropriate use of antimicrobial agents through antimicrobial stewardship program, pharmacokinetics/pharmacodynamics of anti-infective agents.
Guo Y, Chung P, Weiss C, Veltri K, Minamoto G. Customized order entry sets can prevent antiretroviral prescribing errors: a novel opportunity for antimicrobial stewardship. P & T. 2015;40:353-60.
Ostrowsky B, Ruiz R, Bronw S, Chung P, Koppelman E, van Deusen Lukas C, et al. Lessons learned from implementing Clostridium difficile-focused antibiotic stewardship interventions. Infect Control Hosp Epidemiol 2014;35 (Suppl 3):S86-95.
Chung P, Currie B, Guo Y, Talansky M, Brown S, Ostrowsky B. An investigation to identify a resource efficient case-control methodology for determining antibiotics associated with Clostridium difficile infection. Am J Infect Control 2014;42 (Suppl 10):S264-8.
Ostrowsky B, Sharma S, DeFino M, Guo Y, Shah P, McAllen S, Chung P, Brown S, Paternoster J,
Schechter A, Yongue B, Bhalla R. Antimicrobial stewardship and automated pharmacy technology improve antibiotic appropriateness for community acquired pneumonia. Infect Control Hosp Epidemiol 2013;34:566-72.
Ahmad H, Guo Y, Yaghdjian V, Chung P, Ostrowsky B. Hospital emergency response to novel influenza A (H1N1) pandemic in a large New York City hospital: an opportunity for antimicrobial stewardship. Hosp Pharm 2012;47:532-7.
Chung P, McNamara PJ, Campion JJ, Evans ME. Mechanism-based pharmacodynamic models of fluoroquinolone resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2006;50:2957-65.
Campion JJ, Chung P, McNamara PJ, Titlow WB, Evans ME. Pharmacodynamic modeling of the evolution of levofloxacin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2005;49:2189-99.
Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.